bioAffinity Technologies, Inc. (BIAFW)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, bioAffinity Technologies, Inc. reported revenue of $6.16M, down 34.2% from the prior year. The company ran a net loss, with a net margin of -242.0%. It held $10.96M in total assets against $3.68M in total liabilities.
Key ratios (FY2025)
-171.6%
Operating margin
-242.0%
Net margin
-204.9%
Return on equity
-34.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.16M | $9.36M | $2.53M | $4.8K | — | — |
| Cost of Revenue | — | — | — | $467 | — | — |
| Gross Profit | — | — | — | $4.3K | — | — |
| Operating Income | -$10.57M | -$8.95M | -$7.97M | -$4.01M | -$2.21M | — |
| Net Income | -$14.91M | -$9.04M | -$7.94M | -$8.15M | -$6.33M | — |
| EPS (Diluted) | $-8.66 | $-22.50 | $-0.91 | $-1.81 | $-2.36 | — |
| Total Assets | $10.96M | $6.51M | $8.22M | $12.18M | $1.45M | — |
| Total Liabilities | $3.68M | $3.91M | $3.37M | $1.14M | $13.20M | — |
| Shareholders' Equity | $7.28M | $2.60M | $4.86M | $11.04M | -$15.79M | -$15.07M |
| Cash & Equivalents | $6.45M | $1.11M | $2.82M | $11.41M | $1.36M | — |
| Operating Cash Flow | -$9.33M | -$7.26M | -$6.04M | -$4.07M | -$2.05M | — |
| Capital Expenditures | $60.6K | $79.1K | $22.9K | $220.0K | — | — |
| Shares Outstanding | 4.50M | 519.2K | 9.39M | 8.38M | 2.68M | — |